https://articles.mercola.com/sites/articles/archive/2021/10/17/david-martin-covid-fraud.aspx?ui=db1c8443091da8e5adafcb987fb464e0897952a7a94345dffa47df648a2295a5&;sd=20120913&cid_source=dnl&cid_medium=email&cid_content=art2HL&cid=20211017&mid=DM1020578&rid=1295090280

In the early 2000s, David Martin, Ph.D., founder of M-CAM International, started finding large numbers of patents that violate biological and chemical weapons laws
In 1999, Dr. Anthony Fauci funded research to create “an infectious replication-defective recombinant coronavirus.” In 2002, Ralph Baric, Ph.D. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak
Since 1999, at least 4,000 patents involving coronavirus have been filed, including patents detailing key features of the so-called “novel” SARS-CoV-2 virus
The 2001 anthrax attack, which came out of medical and defense research, led to the passage of the PREP Act, which removed liability for manufacturers of emergency medical countermeasures
The funds for entitlement programs and pensions will dry up by 2028, at which point the drug industry will go bankrupt as well. With a burgeoning population that is sick from the COVID jabs, we need to prepare new systems to care for each other
In this interview, we continue our coverage of the COVID “plandemic” by speaking to David Martin, Ph.D., who has done a phenomenal job uncovering the paper trail behind the virus now known as SARS-CoV-2. As it turns out, this is not a novel virus at all, as patents and government grants detailing key features of the virus go back two decades.

Martin finished his doctorate at the University of Virginia in 1995, after which he was hired on to the medical school faculty in radiology and orthopedic surgery. In 2006, he set up the first medical device clinical trials organization for the University of Virginia — a company called IDEAmed — which conducted medical device clinical trials for U.S. Food and Drug Administration submission. So, he has an extensive background working with FDA clinical trials.

Monitoring Biological Weapons Violations
In 1998, he founded another company called M-CAM International, which is focused on finding ways to bring intellectual property into conventional finance. M-CAM also started auditing the U.S. patent system at the request of the U.S. Congress.

In the early 2000s, M-CAM worked with the Senate Banking Committee and was a contractor for the United States Treasury to expose white collar criminal activity around intellectual property and tax fraud. In doing that work, Martin also discovered something else.

“Quite alarmingly, we found an enormous number of patents [detailing] biological and chemical weapon violations,” Martin says. “That was not something we were looking for. I let people know this was not something we set out to find. This is something that landed in our lap.

I developed a technology a decade earlier called linguistic genomics, which is a means by which you can look at unstructured text data and find the metaphoric meaning inside of what is being communicated. As you can imagine, if people of ill intent are trying to do something, they often hide what they're doing in plain sight, but they use language that is not conventional.

So, when you find a patent, for example, on a blast-resistant pathogen from a rocket-propelled grenade — did you hear what I just said? ‘A blast-resistant pathogen from a rocket-propelled grenade.’ Does that sound like it's a common way to inoculate a population or does that sound like [a bioweapon]?

And so, finding a number of bioweapons patents, we started taking into account some very serious things. I published once a year the literal global phonebook of every biological and chemical weapon violation that took place anywhere in the world.

[It tells you] the who, the where, the who funded it, what their addresses are. It was … used by U.S. law enforcement, intelligence communities and elsewhere around the world to track things that were being done inappropriately. And, it was in 1999 [that] we started detecting that there seemed to be an alarming event around coronavirus, which we're going to get into.”